Nuedexta
Does IQ Test Really Measure Intelligence? »
"Dec. 20, 2012 -- Single tests that measure intelligence quotient, or IQ, may become a thing of the past.
A new study of more than 100,000 participants suggests that there may be at least three distinct components of intelligence. So y"...
Read the Does IQ Test Really Measure Intelligence? article »
Nuedexta Capsules
INDICATIONS
NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurologic conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the underlying emotional state.
Studies to support the effectiveness of NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) were performed in patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) has not been shown to be safe and effective in other types of emotional lability that can commonly occur, for example, in Alzheimer's disease and other dementias.
DOSAGE AND ADMINISTRATION
Recommended Dose
The recommended starting dose of NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) is one capsule daily by mouth for the initial seven days of therapy. On the eighth day of therapy and thereafter, the daily dose should be a total of two capsules a day, given as one capsule every 12 hours.
The need for continued treatment should be reassessed periodically, as spontaneous improvement of PBA occurs in some patients.
HOW SUPPLIED
Dosage Forms And Strengths
NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) capsules contain 20 mg dextromethorphan hydrobromide and 10 mg quinidine sulfate in a brick red gelatin capsule with "DMQ/20-10" printed in white ink on the capsule.
NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) is supplied as brick red gelatin capsules imprinted with "DMQ / 20-10". NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) is supplied in the following package configurations:
| Package Configuration | Capsule Strength (mg) | NDC Code |
| Bottles of 13 (sample) | dextromethorphan 20 mg/ quinidine 10 mg | 64597-011-13 |
| Bottles of 60 (30 day supply) | dextromethorphan 20 mg/ quinidine 10 mg | 64597-011-60 |
Storage
Store NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate capsules) capsules at controlled room temperature, 25°C (77°F); excursions permitted to 15° - 30 °C (59° - 86°F) [See USP Controlled Room Temperature].
Marketed by: Avanir Pharmaceuticals, Inc. Aliso Viejo, CA 92656. Revised: 10/2010
Last reviewed on RxList: 12/10/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Nuedexta Capsules Information
Nuedexta Capsules - User Reviews
Nuedexta Capsules User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Nuedexta Capsules sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
